News
Important Only
Haveli to buy majority stake in contract software firm Sirion
By Isla BinnieJan 8 (Reuters) - U.S. private equity firm Haveli Investments has agreed to make a majority investment in Sirion, which provides software that uses artificial intelligence to draft, store and manage business contracts, the companies said on Thursday.WHAT HAS BEEN AGREED?Haveli will buy...Reuters
Thu, Jan 8
Frontier Airlines parent company appoints new CEO
Jan 8 (Reuters) - Frontier Group ULCC.O, parent company of Frontier Airlines, said on Thursday the board appointed James G. Dempsey as its Chief Executive Officer.Last month, the company announced the departure of longtime CEO Barry Biffle and named insider Dempsey as interim chief.Frontier also sai...Reuters
Thu, Jan 8
Benefit Street Partners Secures $10 Billion For Its Flagship U.S. Real Estate Debt Strategy
Jan 8 (Reuters) - Franklin Resources Inc BEN.N:BENEFIT STREET PARTNERS SECURES $10 BILLION FOR ITS FLAGSHIP U.S. REAL ESTATE DEBT STRATEGY, MARKING THE LARGEST FUNDRAISE IN THE FIRM’S HISTORY FOR THE ASSET CLASSReuters
Thu, Jan 8
Biotech Alveus raises $160 million to tackle weight loss maintenance
By Kamal Choudhury Jan 8 (Reuters) - Alveus Therapeutics said on Thursday it has raised $159.8 million in funding to develop obesity treatments focused on helping patients keep weight off long-term, a problem the company says current therapies fail to address.The Series A financing round was led...Reuters
Thu, Jan 8
Airjoule Technologies Begins Net Zero Innovation Hub For Data Centers Program
Jan 8 (Reuters) - AirJoule Technologies Corp AIRJ.O:AIRJOULE TECHNOLOGIES BEGINS NET ZERO INNOVATION HUB FOR DATA CENTERS PROGRAM AND ADVANCES COMMERCIAL DEPLOYMENT WITH GOOGLE, MICROSOFT, AND INDUSTRY LEADERSReuters
Thu, Jan 8
Moonlake Immunotherapeutics Announces Positive Outcome From Type B Meeting With U.S. FDA
Jan 8 (Reuters) - MoonLake Immunotherapeutics MLTX.O:MOONLAKE IMMUNOTHERAPEUTICS ANNOUNCES POSITIVE OUTCOME FROM TYPE B MEETING WITH U.S. FDA AND ANNOUNCES INVESTOR DAYMOONLAKE IMMUNOTHERAPEUTICS - FDA CONFIRMS MOONLAKE CAN ESTABLISH SEE WITHOUT ADDITIONAL TRIALSMOONLAKE IMMUNOTHERAPEUTICS - PLANS B...Reuters
Thu, Jan 8
Charles River Laboratories Announces Planned Retirement Of James C. Foster
Jan 8 (Reuters) - Charles River Laboratories International Inc CRL.N:CHARLES RIVER LABORATORIES ANNOUNCES PLANNED RETIREMENT OF JAMES C. FOSTER AND CEO SUCCESSION PLANCHARLES RIVER LABORATORIES INTERNATIONAL INC: BIRGIT GIRSHICK UNANIMOUSLY APPOINTED NEXT CHIEF EXECUTIVE OFFICER, ALSO EFFECTIVE IN M...Reuters
Thu, Jan 8
Zelenskiy says US security guarantees document set to be finalised with Trump
KYIV, Jan 8 (Reuters) - Ukrainian President Volodymyr Zelenskiy said on Thursday the text of a bilateral security guarantee between Kyiv and Washington was "essentially ready" to be finalised with U.S. President Donald Trump. As a cornerstone of any post-war settlement, Ukraine has soug...Reuters
Thu, Jan 8
Spruce Biosciences Secures Up To $50 Million In Growth Capital From Avenue Capital
Jan 8 (Reuters) - Spruce Biosciences Inc SPRB.O:SPRUCE BIOSCIENCES SECURES UP TO $50 MILLION IN GROWTH CAPITAL FROM AVENUE CAPITALSPRUCE BIOSCIENCES INC - INITIAL FUNDING OF $15 MILLION EXTENDS CASH RUNWAY INTO 2027Reuters
Thu, Jan 8
